Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy;Prevalencia, valor diagnóstico y características clínicas asociadas a la presencia de niveles circulantes y depósitos renales de anticuerpos contra el receptor tipo M de la fosfolipasa A2 en nefropatía membranosa idiopática

Nefrologia

Volumn 34, Issue 3, 2014, Pages 353-359

  Segarra Medrano, Alfonso ^a   Jatem Escalante, Elías ^b   Quiles Pérez, M Teresa ^c   Salcedo, M Teresa ^a   Arbós Via, M Antonia ^c   Ostos, Helena ^a   Valtierra, Naiara ^a   Carnicer Cáceres, Clara ^a   Agraz Pamplona, Irene ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Institut de Reserca Vall d Hebron   (Spain)

Author keywords

Anti PLRA2 antibodies; Elisa; Glomerular diseases; Idiopathic membranous glomerulonephritis; Indirect immunofluorescense

Indexed keywords

AUTOANTIBODY; PHOSPHOLIPASE A2 RECEPTOR;

BLOOD; CLASSIFICATION; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMAN; IMMUNOLOGY; KIDNEY; MALE; MIDDLE AGED; PREVALENCE;

AUTOANTIBODIES; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; KIDNEY; MALE; MIDDLE AGED; PREVALENCE; RECEPTORS, PHOSPHOLIPASE A2;

EID: 84901294571     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2013.Dec.12291     Document Type: Article

References (21)

1. Tiebosch AT, Wolters J, Frederik PF, van der Wiel TW, Zeppenfeldt E, van Breda Vriesman PJ. Epidemiology of idiopathic glomerular disease: a prospective study. Kidney Int 1987;32(1):112-6.
2. Kerjaschki D. Pathomechanisms and molecular basis of membranous glomerulopathy. Lancet 2004;364(9441):1194-6.
3. Debiec H, Ronco P. Fetomaternal alloimmunization with antenatal glomerulopathies. Ann N Y Acad Sci 2007;1110:559-66.
4. Glassock RJ. Human idiopathic membranous nephropathy - a mystery solved? N Engl J Med 2009;361:81-3.
5. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009;361(1):11-21.
6. Hofstra JM, Beck LH Jr, Beck DM, Wetzels JF, Salant DJ. Antiphospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2011;6(6):1286-91.
7. Beck LH Jr, Fervenza FC, Beck DM, Bonegio RG, Malik FA, Erickson SB, et al. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol 2011;22(8):1543-50.
8. Oh YJ, Yang SH, Kim DK, Kang SW, Kim YS. Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy. PLoS One 2013;8(4):e62151.
9. Hofstra JM, Wetzels JF. Anti-PLA2R antibodies in membranous nephropathy: ready for routine clinical practice? Neth J Med 2012;70(3):109-13.
10. Ronco P, Debiec H. Membranous glomerulopathy: the evolving story. Curr Opin Nephrol Hypertens 2010;19(3):254-9.
11. Qin W, Beck LH Jr, Zeng C, Chen Z, Li S, Zuo K, et al. Antiphospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 2011;22(6):1137-43.
12. Ronco P, Debiec H. Advances in membranous nephropathy: success stories of a long journey. Clin Exp Pharmacol Physiol 2011;38(7):410-6.
13. Hofstra J, Debiec H, Short C, Pellé T, Kleta R, Mathieson PW, et al. Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol 2012;23:1735-43.
14. Rees A, Kain R. Nephrotic syndrome: a watershed in the understanding of membranous nephropathy. Nat Rev Nephrol 2009;5:617-8.
15. Salant DJ. In search of the elusive membranous nephropathy antigen. Nephron Physiol 2009;112:p11-2.
16. Ronco P, Debiec H. Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy. J Am Soc Nephrol 2010;21(4):564-9.
17. Debiec H, Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 2011;364(7):689-90.
18. Hoxha E, Zahner G, Velden J, Fechner K, Stege G, Harendza S, Stahl R, Helmchen U. Phospholipase A2 receptor autoantibodies (PLA2R-AB) and increased PLA2R expression in glomeruli discriminate primary from secondary membranous nephropathy (MN) [Abstract]. J Am Soc Nephrol 2011; 22:68A.
19. Levey AS, Stevens SA, Schmid CH, Zhang Y, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12.
20. Hoxha E, Harendza S, Zahner G, Panzer U, Steinmetz O, Fechner K, et al. An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 2011;26(8):2526-32.
21. Kanigicherla DKA, Brenchley PE, Venning M, Poulton KV, McKenzie EA, Gummadova JO, Short CD. Association of anti-PLA2R with disease activity and outcome in idiopathic membranous nephropathy [Abstract]. J Am Soc Nephrol 2011; 22:33A.